📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cytophage

1.1 - Company Overview

Cytophage Logo

Cytophage

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of bacteriophage development.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cytophage

Inositec Logo

Inositec

HQ: Switzerland Website
  • Description: Provider of treatments for soft tissue calcification disorders based on its proprietary Inositune platform of inositol phosphate (IP6) analogs, with lead programs targeting vascular and renal calcification, including orphan indications; founded in 2015 as a spin-off of ETH Zurich.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inositec company profile →
IGeneX Logo

IGeneX

HQ: United States Website
  • Description: Provider of diagnostic solutions for tick-borne diseases, offering culture enhanced PCR, PCR, serology, ImmunoBlots, and FISH tests for Lyme disease, Bartonella, Babesia, and tick-borne relapsing fever, plus tick testing for pathogen detection and training services; engaged in research and development of tests that accurately detect these pathogens.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IGeneX company profile →
Qpex Biopharma Logo

Qpex Biopharma

HQ: United States Website
  • Description: Provider of antibiotic agents addressing critical needs in infectious disease treatment and antimicrobial resistance for inpatient and outpatient care. Portfolio includes QPX7728, an ultra-broad-spectrum beta-lactamase inhibitor; OMNIvance (Xeruborbactam + Meropenem) for gram-negative infections; ORAvance, an oral Xeruborbactam prodrug enhancing oral beta-lactams; and QPX9003, a lipopeptide for MDR gram-negative pathogens.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Qpex Biopharma company profile →
Cubist Logo

Cubist

HQ: United States Website
  • Description: Provider of biopharmaceutical products focused on the research, development, and commercialization of therapies addressing unmet medical needs in the acute care environment; markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cubist company profile →
ILiAD Biotechnologies Logo

ILiAD Biotechnologies

HQ: United States Website
  • Description: Provider of clinical-stage biotech focused on preventing and treating Bordetella pertussis disease, offering BPZE1, a live attenuated pertussis vaccine candidate; the B-Tech program and vector platform for therapeutic development and immune induction; vaccine candidates incl. IB-002A; B. pertussis disease research; and BioLyo services for live biological manufacturing process development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ILiAD Biotechnologies company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cytophage

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cytophage

2.2 - Growth funds investing in similar companies to Cytophage

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cytophage

4.2 - Public trading comparable groups for Cytophage

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cytophage

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cytophage

What does Cytophage do?

Cytophage is a provider of bacteriophage development.

Who are Cytophage's competitors?

Cytophage's competitors and similar companies include Inositec, IGeneX, Qpex Biopharma, Cubist, and ILiAD Biotechnologies.

Where is Cytophage headquartered?

Cytophage is headquartered in Canada.

How many employees does Cytophage have?

Cytophage has 1,000 employees 🔒.

When was Cytophage founded?

Cytophage was founded in 2010 🔒.

What sector and industry vertical is Cytophage in?

Cytophage is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cytophage

Who are the top strategic acquirers in Cytophage's sector and industry

Top strategic M&A buyers and acquirers in Cytophage's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cytophage?

Top strategic M&A buyers groups and sectors for Cytophage include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cytophage's sector and industry vertical

Which are the top PE firms investing in Cytophage's sector and industry vertical?

Top PE firms investing in Cytophage's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cytophage's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cytophage's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cytophage's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cytophage include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cytophage's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cytophage?

The key public trading comparables and valuation benchmarks for Cytophage include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cytophage for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cytophage with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cytophage's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cytophage with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cytophage's' sector and industry vertical?

Access recent funding rounds and capital raises in Cytophage's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cytophage